Reliability of the North Star Ambulatory Assessment in a multicentric setting.
about
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyClinical utility of serum biomarkers in Duchenne muscular dystrophy24 month longitudinal data in ambulant boys with Duchenne muscular dystrophyQuantitative muscle ultrasound in Duchenne muscular dystrophy: a comparison of techniques.Composite biomarkers for assessing Duchenne muscular dystrophy: an initial assessment.Rasch analysis of clinical outcome measures in spinal muscular atrophy.Cross-sectional evaluation of electrical impedance myography and quantitative ultrasound for the assessment of Duchenne muscular dystrophy in a clinical trial setting.Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetingsQuantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures.Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.Evaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy.The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing anCirculating Muscle-specific miRNAs in Duchenne Muscular Dystrophy PatientsThe cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used.Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional studyDiscovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year.Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study.The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boysImportance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophyRevised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy.Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool.Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular DystrophyImprovement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular diseaseThe NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trialIdentification of serum protein biomarkers for utrophin based DMD therapy.A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy.Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy.Development and Reliability of the Functional Evaluation Scale for Duchenne Muscular Dystrophy, Gait Domain: A Pilot Study.Being ambulatory does not secure respiratory functions of Duchenne patients.Quantitative Ultrasound Assessment of Duchenne Muscular Dystrophy Using Edge Detection Analysis.Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study.Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathiesMuscle MRI and functional outcome measures in Becker muscular dystrophy.An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.
P2860
Q24616493-2572C19C-ED01-417B-AE6E-C7A3124971E9Q26751261-BD026739-3D4D-4719-93B3-E099803239E5Q30000819-16675014-A49F-4D0D-8918-15D66AF88F26Q30392474-3209C0E5-E890-4EFA-8088-4145B40A576DQ30392522-E488DD69-564A-4299-B508-1602BE9A3FB4Q30407124-0F6A241C-4BA0-452F-ABE6-17309F9DC3D0Q30408010-8A7AA9A3-E6BE-4422-9A3C-65D42C8CB346Q30514152-39F9D296-64AD-4C54-A2CE-93FC99332C02Q30527775-69092533-A318-4F90-9FBB-AFD4410F185AQ30856806-413B2DEA-DF47-4F10-8FC4-01B371345BA0Q33860859-631FA98F-8481-4717-966A-501EE3AD1FBAQ33919009-E9A573F8-9815-4029-9AC0-E07326AC9FFAQ34001045-A7082371-E15B-480B-B9B1-8C40741CED1BQ34103360-98830248-F04A-4602-A24E-D3C74D2B2DCBQ34155950-A35C8A03-D2A1-49CA-836C-9B78B661A7AFQ34555477-928FB4FC-37DE-4057-8910-36FDF797E431Q34836557-49B981D0-F9DC-410F-8BB3-9B95B94FD891Q34963315-0F10387C-099C-4444-9035-E4C4D63EA997Q35553292-18537E9E-C692-4C5A-8ACF-CEDDF92ED316Q36078440-02441D28-F6F0-4B35-B1C0-6BCD0C4A5214Q36095743-AC602886-38EB-4E6B-8A75-EFA1E4D73F88Q36097194-66F17072-31C3-4330-AAD4-6394661FFA5AQ36286233-ACF23E45-4ED4-4259-8136-C0479C2D1150Q36287980-DA1BF1C5-6DF1-4150-9AC0-58A80308EBACQ36334428-D4E6174D-07AD-4300-9A18-92EF8AE70598Q36351131-469CEE00-02D7-4D7E-A298-D3D9692CEA2CQ36577433-609ACAD9-F7DD-4BC1-B6EA-CB26A0F1988FQ37095860-CDB27035-260A-481C-AEAA-FDA76390D7D8Q37150891-D4FBD311-9F60-4AE7-8CE6-01B85E27F63BQ37676311-EC0FFC2F-3177-4EB1-9432-FB6D8549F80FQ38019990-9D92F469-D65C-4896-8BBC-7F99137CE27DQ38125499-588F1C53-D554-40E1-A279-19AB51C731D5Q38292941-F5C30D49-9F9C-492F-8C37-922909C6AB6BQ38804184-35D2E7E7-EC91-49EE-B1A5-BB36CBEB7453Q38897227-AD80022F-F5ED-494A-99C8-11D03DD73EF8Q39771316-854244CB-A8AC-4656-9179-655A44ECA49CQ39847054-9D4B7569-2F6F-4AA1-8BEC-A8FA60A96624Q40991213-4054F8B6-B6F1-4AFB-B19B-1D2AC5F60CF8Q47102881-FA87EAD5-77BB-454A-9588-66A039AC73D2Q47607031-8D7EF8D3-48FF-4106-BE81-8D9FD779A3D2
P2860
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
@en
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
@nl
type
label
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
@en
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
@nl
prefLabel
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
@en
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
@nl
P2093
P50
P1476
Reliability of the North Star Ambulatory Assessment in a multicentric setting
@en
P2093
A Corlatti
B Brancalion
E Pegoraro
E S Mazzone
E Zucchini
F Cavallaro
P304
P356
10.1016/J.NMD.2009.06.368
P50
P577
2009-06-23T00:00:00Z